key: cord-0976131-um8q2l5p
authors: Robinson, Cal H.; Chanchlani, Rahul
title: High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health
date: 2022-03-01
journal: Kidney Int Rep
DOI: 10.1016/j.ekir.2022.02.018
sha: 9e3d291cceb7a0be29ba7f1883fb1af61ebbe2f5
doc_id: 976131
cord_uid: um8q2l5p

Hypertension is one of the most common causes of preventable death worldwide. The prevalence of pediatric hypertension has increased significantly in recent decades. The cause of this is likely multifactorial, related to increasing childhood obesity, high dietary sodium intake, sedentary lifestyles, perinatal factors, familial aggregation, socioeconomic factors, and ethnic blood pressure (BP) differences. Pediatric hypertension represents a major public health threat. Uncontrolled pediatric hypertension is associated with subclinical cardiovascular disease and adult-onset hypertension. In children with chronic kidney disease (CKD), hypertension is also a strong risk factor for progression to kidney failure. Despite these risks, current rates of pediatric BP screening, hypertension detection, treatment, and control remain suboptimal. Contributing to these shortcomings are the challenges of accurately measuring pediatric BP, limited access to validated pediatric equipment and hypertension specialists, complex interpretation of pediatric BP measurements, problematic normative BP data, and conflicting society guidelines for pediatric hypertension. To date, limited pediatric hypertension research has been conducted to help address these challenges. However, there are several promising signs in the field of pediatric hypertension. There is greater attention being drawn on the cardiovascular risks of pediatric hypertension, more emphasis on the need for childhood BP screening and management, new public health initiatives being implemented, and increasing research interest and funding. This article summarizes what is currently known about pediatric hypertension, the existing knowledge-practice gaps, and ongoing research aimed at improving future kidney and cardiovascular health.

H ypertension is one of the most common causes of preventable global disease and death. [1] [2] [3] Global hypertension prevalence has doubled from 1990 to 2019, but less than half of the patients with hypertension are diagnosed and less than one-quarter are adequately controlled. 2 Significant global disparities exist, with lower rates of hypertension diagnosis, treatment, and control in low-and middle-income countries. 2, 4 There is strong evidence that pediatric hypertension tracks into adulthood and is associated with premature cardiovascular and kidney diseases. 5-12 Therefore, early detection and adequate management of pediatric hypertension should be prioritized.

The prevalence of pediatric hypertension has increased in recent decades, contributed partly by rising childhood obesity. 13,14 However, rates of pediatric hypertension depend on the definition used, which have changed over time and vary globally (Table 1) . 5, 15, 16, 17 Without direct evidence linking specific BP thresholds to cardiovascular outcomes, pediatric hypertension is defined using normative distributions. Between 3% and 5% of children and adolescents have hypertension and 10% and 14% have elevated BP levels ("prehypertension"). 13, 14, [18] [19] [20] In a global meta-analysis, the pooled prevalence of hypertension was 4.0% and Familial aggregation of hypertension is well known. Genetic factors significantly contribute, as demonstrated by the stronger association between parent/ child BP than between spouses 34 and lack of BP correlation between parents and adopted children. 35, 36 Familial and twin studies demonstrate that BP heritability is w30% to 50%. 37-40 Genome-wide association studies have identified many BP loci, although each individually accounts for small BP differences (<1 mm Hg). [41] [42] [43] Epigenetic and gene-environment interactions are likely significant. Multiple perinatal factors are associated with childhood BP, including low birthweight, prematurity, and maternal factors (i.e., pre-eclampsia, BP, age, and body mass index). [44] [45] [46] [47] These factors can impair nephrogenesis, predisposing affected individuals to hypertension and salt sensitivity. 48-52 A systematic review by Rabe et al. 53 found some evidence that maternal age, BP, body mass index, and smoking were associated with neonatal BP, although there are insufficient published data. Postnatally, breastfeeding has been consistently associated with lower childhood BP level. 53-58 Lower sodium exposure in breastfed infants is a potential contributor. 59 Obesity, Diet, and Physical Activity Obesity is a major risk factor for pediatric hypertension. [60] [61] [62] [63] [64] The risk of hypertension is 2.6Â greater in overweight children (body mass index-for-age $85th percentile) 65 and 9.2Â greater in obese children ($95th percentile). 65 Obesity-hypertension begins early in children (<5 years). [66] [67] [68] The mechanisms of obesityhypertension are complex but include impaired sodium handling, sympathetic nervous system overactivation, oxidative stress, hemodynamic changes, and renal/endocrine dysfunction. 69 Physical activity is inversely associated with childhood obesity and directly counteracts obesity-hypertension mechanisms. 70 Dietary sodium intake is also closely associated with BP. 13, 71, 72 In North American children, daily sodium intake is w3000 mg to 3400 mg (approximately 2-3 times the recommended daily intake), and threequarters of Canadian children exceed upper tolerable limits. [73] [74] [75] Approximately 80% of dietary sodium comes from packaged and processed foods. 74 Salt sensitivity (i.e., BP rise following sodium intake) is an important mediator. 76 Individuals with hypertension, obesity, low birthweight, and African Americans have greater salt sensitivity, which is associated with increased target organ damage, cardiovascular disease, and mortality. [77] [78] [79] [80] However, assessing an individual's salt sensitivity is still clinically impractical. Salt sensitivity testing requires either strict adherence to high and low sodium diets on a prolonged outpatient protocol, or i.v. sodium loading studies, neither of which are practical for most children with hypertension.

Ethnic Differences, Socioeconomic Status, and the Developing World Significant racial and ethnic BP differences are well characterized in adults. [81] [82] [83] [84] Minority ethnic groups are consistently shown to have more hypertension and worse BP control. [81] [82] [83] 85, 86 BP level is also higher among Black, Hispanic, and Asian children. [87] [88] [89] Associations are reported between low socioeconomic status, parental income, and education with childhood BP. [90] [91] [92] [93] [94] Kelly et al. 94 found that socioeconomic status improvement into adulthood significantly decreased BP level. In a metaanalysis by Beltrán et al., 95 food insecurity was significantly associated with hypertension (odds ratio 1.44, 95% CI 1.16-1.79). Ethnic and socioeconomic differences may relate to diet (i.e., access to high-quality foods and salt intake), obesity, prenatal factors, timing of sexual maturity, psychological stress, and health care access.

Although hypertension detection and management have improved significantly in high-income countries, Figure 1 . Barriers and knowledge-practice gaps leading to suboptimal pediatric hypertension care. Estimates are provided for the proportion of children in each of the referenced studies that fit the stated description. These are included to provide approximations of the proportion of children who receive suboptimal care at each stage, including population BP screening, follow-up of elevated BP readings, diagnosis of hypertension, management of hypertension, and adequate BP control. Details of the specific populations included and study methods can be found in the references provided. Aside from the studies of hypertension control in children with CKD, all of the other referenced studies were conducted in the United States (and 1 Canadian study 21 ). There may be significant global practice variation in pediatric hypertension care. Without data from other countries, it is not possible to extrapolate beyond the North American context. We used existing guidelines at the time of study publication to define what proportion of children received "suboptimal care." These guidelines were the NHLBI fourth report (from 2004 to 2017), the AAP 2017 guidelines (from 2017 to present), and the KDIGO guidelines (for children with CKD). 5,17,22 ABPM, ambulatory BP monitoring; AAP, American Academy of Pediatrics; BP, blood pressure; CKD, chronic kidney disease; KDIGO, Kidney Disease Improving Global Outcomes; NHLBI, National Heart Lung and Blood Institute.

CH Robinson and R Chanchlani: Blood Pressure Management in Children the same is not true in the developing world. 2, 4 High rates of tobacco use, salt intake, and obesity contribute to high hypertension prevalence, whereas low health literacy and limited health care access are major barriers to adequate hypertension control. These issues may be further exacerbated by rapid urbanization in low-and middle-income countries. 4, [96] [97] [98] Pediatric Hypertension Outcomes Although uncontrolled adult hypertension is clearly associated with cardiovascular disease and mortality, there is limited direct evidence for hard cardiovascular outcomes in pediatric hypertension. Demonstrating this association would require a large cohort of children with hypertension, many decades of follow-up, and high participant retention, which is neither financially nor practically feasible. However, there is substantial evidence that pediatric BP tracks into adulthood and that pediatric hypertension increases the risk of subclinical cardiovascular disease ("target organ damage"). 5-7,99

Children with hypertension and adolescents are more likely to become adults with hypertension, although the correlation is incomplete. 9-12,95,100-104 Reported correlation coefficients between childhood and adult BP are 0.2 to 0.5 (weak-to-moderate correlation). 9,10,12,94,104 However, BP tracking between adolescence and adulthood and among obese individuals is stronger. 10-12 Individuals with persistent hypertension (through childhood and adolescence) have a 7.6Â greater odds of adult hypertension. 12 Of note, many children with hypertension have BP normalization over time. In 1881 children with hypertension, nearly three-quarters had normal or only elevated BP level in the following 3 years. 105 Factors associated with BP normalization include decreased body mass index, increased vegetable intake, decreased alcohol use, and improved socioeconomic status. 95 

Pediatric hypertension is associated with target organ damage, which in turn is associated with future cardiovascular disease. Children with hypertension have higher left ventricular mass index and left ventricular hypertrophy (LVH). [106] [107] [108] [109] [110] [111] [112] [113] [114] Between 5% and 50% of children with hypertension have LVH, and a dosedependent relationship is shown with increasing BP severity. 115, 116 Children with hypertension also have increased carotid intima-media thickness, 117-120 higher pulse-wave velocity, 121,122 arterial calcification and atherosclerotic changes, [123] [124] [125] [126] [127] retinal microvascular disease, [128] [129] [130] and microalbuminuria. 131, 132 In a large cohort of Israeli military recruits (16-19 years old), adolescent hypertension was associated with an increased risk of long-term kidney failure, as defined In adults, these subclinical cardiovascular outcomes are consistently associated with an increased risk of cardiovascular events. 127,133-136 However, pediatric data demonstrating a direct association between these subclinical outcomes, mortality, and clinical cardiovascular events are lacking. To further explore these associations, the Study of High Blood Pressure in Pediatrics: Adult Hypertension Onset in Youth study is establishing a multiethnic cohort of adolescents to define optimal BP thresholds and evaluate markers of hypertensive target organ damage. 137 Fortunately, antihypertensive treatment is shown to improve LVH in pediatric studies, including patients with CKD. [138] [139] [140] [141] [142] Hypertension in Pediatric CKD

Hypertension is strongly associated with CKD progression in children and adults, and BP lowering prevents CKD progression. [143] [144] [145] [146] [147] [148] In childhood CKD, hypertension is common (48%-70%), [149] [150] [151] [152] [153] [154] [155] and <50% are adequately controlled. [149] [150] [151] [152] [153] [156] [157] [158] In the Chronic Kidney Disease in Children study, 83% of the participants had ambulatory hypertension (including abnormal BP load) and 35% had masked hypertension. 157 The optimal BP target in pediatric CKD has not been established ( Table 1 ). The Kidney Disease: Improving Global Outcomes 2021 guidelines recommend a systolic BP target <120 mm Hg for adults with hypertension and CKD. 159 In children, the Kidney Disease: Improving Global Outcomes guidelines recommend targeting a 24-hour mean arterial pressure (MAP) <50th percentile (level 2C; weak recommendation, low-quality evidence). This is supported by the Effect of Strict Blood Pressure Control and ACE Inhibition on the Progression of CKD in Pediatric Patients (ESCAPE) trial (385 participants), which demonstrated lower CKD progression with intensive BP control, particularly in proteinuric kidney disease. 144 Recent data from the Chronic Kidney Disease in Children study also found that high MAP (>90th percentile) was associated with CKD progression. 149 However, using ABPM-based targets for pediatric hypertension management is impractical and limits global applicability. The 2016 guidelines of the European Society of Hypertension instead recommend an office-based BP target of #75th percentile (nonproteinuric CKD) and of #50th percentile (proteinuric CKD). 15

Standardized, reliable BP measurement is critical to hypertension diagnosis. Unfortunately, pediatric BP measurement is challenging. In North America, pediatric BP screening, elevated BP level follow-up, and hypertension diagnosis are suboptimal ( Figure 1 ). There are minimal data on the extent of pediatric hypertension screening in low-to middle-income countries, where underdiagnosis may be more prevalent.

Office-based BP was traditionally measured using mercury sphygmomanometers. These have been gradually replaced by aneroid sphygmomanometers, although there are limited pediatric validation data, and these require routine calibration. Oscillometric devices are popular, given their ease of use and consistency. They overcome observer bias and prevent terminal digit preference (i.e., rounding measurements to certain digits). However, oscillometric devices estimate systolic and diastolic BP levels using proprietary formulas by measuring MAP and pulse pressure. Significant differences may exist between oscillometric devices, and they tend to overestimate pediatric BP level by 3 to 10 mm Hg. [160] [161] [162] Normative BP data are typically derived by auscultatory methods, so abnormal oscillometric BP should be confirmed by auscultation. 5,15,16 Repeated or averaged BP measurements are also more reliable, because BP level can decrease during a single visit. 163, 164 Newer automated devices can repeat BP measurements in clinic without an observer present and have been shown to reduce white coat phenomenon in adults. 165 Elevated BP level should be confirmed on 3 separate visits to diagnose hypertension. 88 

Ambulatory BP is more reproducible and better associated with target organ damage than office-based BP. [167] [168] [169] There are limited pediatric data on home BP monitoring (HBPM), 170 although it is commonly used (>70% of surveyed German pediatric nephrologists 171 ) and has gained popularity during the COVID-19 pandemic. 172 HBPM provides a more longitudinal BP assessment than either office-based BP or ABPM, is cost-effective, and is well tolerated. 173, 174 Although not recommended for pediatric hypertension diagnosis, HBPM can help detect white coat or masked hypertension. HBPM is also useful for BP monitoring in patients with hypertension, especially when strict BP control is desired. 5,15 However, there can be reporting bias, the optimal timing of measurements is unknown, and validated pediatric devices and cuff sizes are lacking. 15 HBPM should be supported by adequate caregiver training and device calibration with office-based auscultatory BP. Telemedicine strategies for hypertension management, including BP telemonitoring, have been shown to be feasible and associated with improved BP control in adults with hypertension. 175 However, there are minimal data on the use of BP telemonitoring in children. Incorporation of these strategies could improve access to pediatric hypertension care, may promote disease selfmanagement, and enhance lifestyle modification. However, these potential benefits are balanced against limited access to validated pediatric home BP devices, a lack of standardized protocols for HBPM, few pediatric telemedicine services, regulatory and privacy issues, and provider reimbursement considerations. 175 Further research on the clinical application of HBPM in children is needed to facilitate BP telemonitoring programs. 170 ABPM is the gold standard for adults and is recommended by the European Society of Hypertension and the American Academy of Pediatrics for children (>5 years). 5,15 ABPM is well correlated with target organ damage [167] [168] [169] and is reliable in pediatric CKD. 144 It can detect nocturnal and masked hypertension, which are both more common in CKD. 158, 159 An "ABPM-first" approach for pediatric hypertension referrals (i.e., performing ABPM in all new referrals to confirm hypertension before consultation and to avoid unnecessary expensive secondary hypertension workups) is a potential cost-saving strategy. 176 However, there are limitations to widespread pediatric ABPM utilization. There are few validated pediatric devices, costs are prohibitive, and global access is limited. Existing ABPM normative data are also problematic. Current normative data were derived from a relatively small Caucasian German population. 177, 178 There are minimal data for children <120 cm in height, and concerns exist regarding low diastolic BP variation in this cohort. BP varies by ethnicity and geographic region. Xi et al. 179 attempted to create international normative BP data from 52,636 children in 7 countries using office-based BP methods. Median systolic/diastolic BP levels varied up to 10 mm Hg between countries, with India and Poland having the highest BP level. Based on these differences in BP by ethnicity, existing ABPM normative data may not be applicable to non-Caucasian children. Yip et al. 180 developed ABPM normative data for East Asian children in Hong Kong, and BP values were 5 to 6 mm Hg higher than those in Caucasian children. There are ongoing efforts to develop validated normative data sets in other ethnicities, including South Asian children in Canada in the Ambulatory blood pressure monitoring for SoutH Asian children study. 181 Another limitation is the existing pediatric ABPM classification. In adults, ambulatory hypertension is defined by simple thresholds (i.e., mean wake BP > 130/80 mm Hg, sleep BP > 110/65, or 24-hour BP > 125/75), that predict cardiovascular events. 182, 183 In the pediatric American Heart Association guidelines, ambulatory hypertension is categorized by mean BP and BP load. 169 However, up to 20% to 40% of children are unclassified using these criteria and hypertension thresholds may be higher than adult thresholds for children $12 years old. [184] [185] [186] There is emerging evidence that isolated elevated BP load is not significantly associated with target organ damage. 185, 187, 188 Removing BP load criteria and using adult thresholds for adolescents would simplify ABPM interpretation. 186, 188 Because oscillometric ABPM devices measure MAP, it may also be preferable to classify ABPM using MAP, instead of calculated systolic/diastolic BP.

Optimal pediatric BP thresholds are unknown (Table 1) , but the goal is to reduce BP to a level that minimizes cardiovascular and kidney disease risks. In adults with hypertension, the Systolic Blood Pressure Intervention Trial demonstrated that intensive BP control (systolic BP target <120 mm Hg) was associated with a significantly lower risk of cardiovascular outcomes, 189 which has led to the incorporation of lower BP targets in recent adult hypertension guidelines. 182, 190 Strategies to improve pediatric hypertension typically address the individual level. However, pediatric hypertension is a growing pandemic, and effective population-based interventions are essential to address the global disease burden (Figure 2 ). Improving awareness of pediatric hypertension among primary care physicians, community organizations, and families may increase detection, provide earlier treatment opportunities, and mitigate adverse consequences.

Population-based sodium reduction strategies are highly cost-effective. 191 In Finland and the United Kingdom, public health campaigns, food industry regulations, and product labeling have successfully decreased population sodium intake by 15% to 40%. 192 Public health strategies should also address childhood obesity and sedentary lifestyles, including awareness campaigns, creating safe spaces for physical REVIEW CH Robinson and R Chanchlani: Blood Pressure Management in Children activity, integrating exercise into schools and communities, and improving access to high-quality nutrition (e.g., through food taxes, subsidies, and school-based programs). 4 In 2013, the World Health Organization created a Global Action Plan for the control of noncommunicable diseases and described a series of "best buy" interventions, considered to be the most cost effective and feasible. These include reducing tobacco and alcohol use, reducing salt and transfat intake, and public health physical activity campaigns. 193 In rural South Asia, the COBRA-BPS trial found that a multicomponent community hypertension intervention (including community health education, BP monitoring, provider training in hypertension management, designated hypertension clinics, and additional funding) significantly improved hypertension control and was cost effective. 194, 195 Strategies to improve pregnancy outcomes, early childhood education, and nutrition are also critical. The Carolina Abecedarian Project found that an early childhood education and nutrition program significantly decreased adult hypertension. 196 

Effective nonpharmacologic strategies for pediatric BP lowering include weight loss (for overweight children), regular physical activity, reduced sodium intake, the Dietary Approaches to Stop Hypertension diet, and smoking/alcohol avoidance ( Figure 2 ). There is strong evidence in both adults and children that dietary sodium reduction is associated with improved BP control, in a dose-dependent relationship. [197] [198] [199] In 2 pediatric meta-analyses (966 and 58,531 patients respectively), reduced dietary sodium intake was associated with small, but significant BP reductions (w1 mm Hg). 199, 200 The association between BP and sodium intake was stronger in overweight children and children with low potassium intake. 199 Achieving sustainable sodium reductions is challenging, given the sodium content in processed foods. 75 Although optimal sodium reduction targets for children are uncertain, the National Academic of Sciences, Engineering and Medicine have recommended Chronic Disease Risk Reduction Intake limits, based on extrapolated adult data (1-3 years: <1200 mg/d; 4-8 years: <1500 mg/d; 9-13 years: <1800 mg/d; 14-18 years: <2300 mg/d). 76 A practical approach for sodium reduction is to recommend a no added salt diet, a reduction of high-salt, processed foods, and to provide education to families regarding food label interpretation. Self-reported sodium intake is also inaccurate. 201 Urine sodium excretion is more reliable, and novel formulas to estimate sodium excretion from spot urine samples are available. [201] [202] [203] Higher sodium excretion is associated with major cardiovascular events. 204 The Dietary Approaches to Stop Hypertension diet was designed in the 1990s as an optimal BP-lowering diet for adults. 205 The Dietary Approaches to Stop Hypertension diet promotes consumption of vegetables, fruit, lean meat, and dairy, and reduces intake of sodium, saturated fat, added sugars, and highly processed foods. The Dietary Approaches to Stop Hypertension diet has also been shown to improve BP in children and adolescents, although there are limited published data. 206, 207 Regular physical activity has also been shown to reduce BP in children and adolescents with hypertension. [208] [209] [210] However, the results of published studies are inconsistent and the effect size is generally small. Physical activity interventions appear to be more effective when combined with diet or weight loss programs. 209 

Nonpharmacologic interventions should be optimized before antihypertensive treatment. Antihypertensive medications should be selected based on underlying hypertension pathophysiology, anticipated efficacy, side effects, available formulations, and associated costs. 5 Long-acting medications and simplified dosing schedules can improve compliance. Few pediatric trials compare antihypertensive medications. A systematic review by Simonetti et al. 211 found that angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and calcium channel blockers had similar antihypertensive efficacy. A 2014 Cochrane review found that angiotensinconverting enzyme inhibitors, angiotensin II receptor blockers, and beta-blockers each significantly reduced BP versus placebo, whereas calcium channel blockers did not. 212 A subsequent network metaanalysis by Burrello et al. 213 found similar BP reductions across antihypertensive classes, but only renin-angiotensin-aldosterone system inhibitors significantly reduced BP versus placebo. Generally, renin-angiotensin-aldosterone system inhibitors are considered first-line pediatric antihypertensives, particularly in CKD. 144 Calcium channel blockers are considered for sexually active adolescent females or if laboratory surveillance (for renin-angiotensinaldosterone system inhibitors) is poorly tolerated. 5,15,16 Samuel et al. 214 described a novel antihypertensive selection approach, by conducting serial n-of-1 trials in 42 children with ABPM, identifying each patient's "preferred" medication (49% lisinopril, 24% amlodipine, and 12% hydrochlorothiazide).

Despite significant advances in pediatric hypertension research, knowledge gaps persist. It is unclear what BP thresholds are associated with cardiovascular outcomes and should be targeted. We must determine the optimal intermediate markers (e.g., LVH) for predicting cardiovascular events. Because BP tracking and target organ damage are incomplete, we must identify relevant predictive factors. We should also evaluate the effect of hypertension duration on cardiovascular outcomes. It remains unclear if transient hypertension (i.e., during childhood chemotherapy) has long-term risks and warrants treatment. The optimal role and timing of HBPM and ABPM are unclear, and progress is needed to validate and improve access to pediatric devices. Additional ABPM normative data sets are needed, in diverse ethnic populations. Finally, further trials are needed to evaluate various antihypertensive medications, particularly among specific populations (e.g., obesity, nonproteinuric CKD, and congenital heart disease). Fortunately, ongoing research will help answer some of these questions, including the Study of High Blood Pressure in Pediatrics: Adult Hypertension Onset in Youth study, 138 further Chronic Kidney Disease in Children analyses (https://statepi.jhsph.edu/ ckid), the Ambulatory blood pressure monitoring for SoutH Asian children study, the Pediatric Hypertension Registry, prospective longitudinal cohorts including the Young Finns study (https:// youngfinnsstudy.utu.fi), and novel intervention trials (e.g., pharmacist-or youth-led programs, n-of-1 medication trials, and clinical decision support tools). 

The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors

Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension

Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg

Long-term effects of neonatal sodium restriction on blood pressure

Intensified effect of adiposity on blood pressure in overweight and obese children

Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications

Is the prevalence of hypertension in overweight children overestimated?

Emergence of sex differences in prevalence of high systolic blood pressure: analysis of a longitudinal adolescent cohort

Development of hypertension in adolescents with pre-hypertension

The relationship of body mass index and blood pressure in primary care pediatric patients

Size at birth, infant growth, and blood pressure at three years of age

Physical activity, obesitystatus, andbloodpressureinpreschool children

Obesity: a perspective from hypertension

Novelty in hypertension in children and adolescents: focus on hypertension during the first year of life, use and interpretation of ambulatory blood pressure monitoring, role of physical activity in prevention and treatment, simple carbohydrates and uric acid as risk factors

Salt and blood pressure in children and adolescents

Sodium intake and blood pressure among US children and adolescents. Pediatrics

Dietary intake of sodium by children: why it matters

Salt sensitivity and hypertension

Salt sensitivity, pulse pressure, and death in normal and hypertensive humans

Evolution of blood pressure from adolescents to youth in salt sensitivies: a 18-year follow-up study in Hanzhong children cohort

Association between salt sensitivity and target organ damage in essential hypertension

Dietary salt intake, salt sensitivity, and cardiovascular health

Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004

Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States

Racial differences in hypertension: implications for high blood pressure management

Ethnic differences in cardiovascular disease risk factors: a systematic review of North American evidence

Racial and ethnic subgroup disparities in hypertension prevalence, New York City health and nutrition examination survey

Centers for Disease Control and Prevention (CDC). Prevalence of hypertension and controlled hypertension -United States

Race and obesity in adolescent hypertension

Blood pressure differences by ethnic group among United States children and adolescents

Prehypertension and hypertension in community-based pediatric practice

Who is at higher risk of hypertension? Socioeconomic status differences in blood pressure among Polish adolescents: a population-based ADOPOLNOR study

A nationwide report on blood pressure of children and adolescents according to socioeconomic status: the CASPIAN-IV study

Explaining socioeconomic inequalities in childhood blood pressure and prehypertension: the ABCD study

Socioeconomic status and hypertension: a meta-analysis

Factors affecting tracking of blood pressure from childhood to adulthood: the childhood determinants of adult health study

Food insecurity and hypertension: a systematic review and meta-analysis

Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study

Urbanization in developing countries: current trends, future projections, and key challenges for sustainability

The global burden of chronic diseases: overcoming impediments to prevention and control

Risk of subclinicalcardiovascular outcomes in children with ambulatory hypertension: a systematic review and meta-analysis

Serial changes in blood pressure from adolescence into adulthood

Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics

Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa heart study

A 15-year longitudinal study on ambulatory blood pressure tracking from childhood to early adulthood

Persistent hypertension in children and adolescents: a 6-year cohort study

Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension

Left atrial size in children with hypertension: the influence of obesity, blood pressure, and left ventricular mass

Relation of childhood risk factors to left ventricular hypertrophy (eccentric or concentric) in relatively young adulthood (from the Bogalusa Heart Study)

Long-term excessive body weight and adult left ventricular hypertrophy are linked through later-life body size and blood pressure: the Bogalusa heart study

Trajectories of childhood blood pressure and adult left ventricular hypertrophy: the Bogalusa heart study

The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children

Cardiac and vascular consequences of prehypertension in youth: cardiovascular consequences of pre-hypertension in youth

Blood pressure trajectories from childhood to young adulthood associated with cardiovascular risk: results from the 23-year Longitudinal Georgia stress and heart study. Hypertension

Impact of long-term burden of excessive adiposity and elevated blood pressure from childhood on adulthood left ventricular remodeling patterns: the Bogalusa Heart Study

Left ventricular hypertrophy in hypertensive children and adolescents: predictors and prevalence

Left ventricular hypertrophy in pediatric hypertension: a mini review

Combined effects of child and adult elevated blood pressure on subclinical atherosclerosis: the International Childhood Cardiovascular Cohort Consortium

Assessment of carotid intima-media thickness as an early marker of vascular damage in hypertensive children

Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study

Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure

Childhood blood pressure as a predictor of arterial stiffness in young adults: the Bogalusa heart study

Simplified definitions of elevated pediatric blood pressure and high adult arterial stiffness

Histologic features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population: the Bogalusa Heart Study

Influence of blood pressure on retinal vascular caliber in young children

Influence of blood pressure and body mass index on retinal vascular caliber in preschool-aged children

Arterial and retinal vascular changes in hypertensive and prehypertensive adolescents

Microalbuminuria in children with primary and white-coat hypertension

Microalbuminuria in children with primary hypertension

Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension

Competing cardiovascular outcomes associated with electrocardiographic left ventricular hypertrophy: the Atherosclerosis Risk in Communities Study

Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis

Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease

SHIP-AHOY (study of high blood pressure in pediatrics: adult hypertension onset in youth): rationale, design, and methods

Regression of target organ damage in children and adolescents with primary hypertension

Control of hypertension in treated children and its association with target organ damage

Regression of leftventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy

Change in cardiac geometry and function in CKD children during strict BP control: a randomized study

BP control and left ventricular hypertrophy regression in children with CKD

Strict bloodpressure control and progression of renal failure in children

Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood

Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic review and meta-analysis

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patientlevel meta-analysis

Mean arterial pressure and chronic kidney disease progression in the CKiD cohort. Hypertension

Blood pressure in children with chronic kidney disease: a report from the chronic kidney disease in children study

Hypertension in pediatric long-term hemodialysis patients in the United States

Predictors of blood pressure and its control in pediatric patients receiving dialysis

Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe

Cardiovascular phenotypes in children with CKD: the 4C study

Prevalence of complications in children with chronic kidney disease according to KDOQI

Hypertension in pediatric patients on long-term dialysis: a report of the North American

Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Ambulatory blood pressure patterns in children with chronic kidney disease. Hypertension

Masked hypertension associates with left ventricular hypertrophy in children with CKD

Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Comparison of auscultatory and oscillometric blood pressures

Oscillometric and auscultatory blood pressure measurement methods in children: a systematic review and meta-analysis

Reliability of resting blood pressure measurement and classification using an oscillometric device in children with chronic kidney disease

Performance of blood pressure measurements at an initial screening visit for the diagnosis of hypertension in children

Is one measurement enough to evaluate blood pressure among adolescents? A blood pressure screening experience in more than 9000 children with a subset comparison of auscultatory to mercury measurements

Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: a systematic review and meta-analysis

Prediction of ambulatory hypertension based on clinic blood pressure percentile in adolescents

Ambulatory blood pressure monitoring and target organ damage in pediatrics

Out-of-office blood pressure and target organ damage in children and adolescents: a systematic review and meta-analysis

Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association

Home blood pressure monitoring in children and adolescents: systematic review of evidence on clinical utility

Measurement of blood pressure at home: survey among pediatric nephrologists

Survey of telemedicine by pediatric nephrologists during the COVID-19 pandemic

Cost estimation of hypertension management based on home blood pressure monitoring alone or combined office and ambulatory blood pressure measurements

Patients' preference for ambulatory versus home blood pressure monitoring

Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper

Clinical predictors and impact of ambulatory blood pressure monitoring in pediatric hypertension referrals

Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions

Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects

Establishing international blood pressure references among nonoverweight children and adolescents aged 6 to 17 years

Oscillometric 24-h ambulatory blood pressure reference values in Hong Kong Chinese children and adolescents

Deriving normative data on 24-hour ambulatory blood pressure monitoring for South Asian children (ASHA): a clinical research protocol

PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines

Outcome-driven thresholds for ambulatory blood pressure based on the new American College of Cardiology/American Heart Association classification of hypertension

Impact of ambulatory blood pressure monitoring on the diagnosis of hypertension in children

Prognostic value of ambulatory blood pressure load in pediatric CKD

Pediatric ambulatory blood pressure classification: the case for a change. Hypertension

Pediatric and adult ambulatory blood pressure thresholds and blood pressure load as predictors of left ventricular hypertrophy in adolescents

Elevated load with normal mean in pediatric hypertension (HTN): what does it mean?

A randomized trial of intensive versus standard bloodpressure control

ESC/ESH guidelines for the management of arterial hypertension

Population strategies to decrease sodium intake and the burden of cardiovascular disease: a costeffectiveness analysis

Impact of salt reduction in Finland and the United Kingdom. World Health Organization

From burden to "best buys": reducing the economic impact of non-communicable disease in low and middleincome countries

A community-based intervention for managing hypertension in rural South Asia

Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural

Early childhood investments substantially boost adult health

Blood pressure effects of sodium reduction: dose-response meta-analysis of experimental studies

Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials

Sodium intake and blood pressure in children and adolescents: a systematic review and meta-analysis of experimental and observational studies

Importance of salt in determining blood pressure in children: meta-analysis of controlled trials

Urine spot samples can be used to estimate 24-hour urinary sodium excretion in children

Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study

Urinary sodium and potassium excretion, mortality, and cardiovascular events

24-hour urinary sodium and potassium excretion and cardiovascular risk

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet

Dietary approaches to stop hypertension dietary intervention improves blood pressure and vascular health in youth with elevated blood pressure

Influence of dietary approaches to stop hypertension-type diet, known genetic variants and their interplay on blood pressure in early childhood: ABCD study

The effects of exercise on resting blood pressure in children and adolescents: a meta-analysis of randomized controlled trials

Effect of childhood obesity prevention programs on blood pressure: a systematic review and meta-analysis

Longterm predictors of blood pressure among adolescents during an 18-month school-based obesity prevention intervention

Effects of antihypertensive drugs on blood pressure and proteinuria in childhood

Pharmacological interventions for hypertension in children. Evid Based Child Health

Pharmacological treatment of arterial hypertension in children and adolescents: a network meta-analysis. Hypertension

Treating hypertension in children with n-of-1 trials

The authors thank Dr. Sujane Kandasamy for her assistance in preparing the manuscript figures and infographics.